
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize…

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize…
Founded: 2016
Headquarters: San Francisco / Berkeley, CA area
Tech focus: 3D bioprinted lymph node organoids + AI/ML for antibody discovery (EXIS™)
Recent funding: Series C activity recorded (latest date Mar 10, 2025)
Antibody discovery and therapeutic development using human-relevant in vitro models; long-term organ engineering for transplantation.
2016
Biotechnology Research
14,500,000
Series B reported at $14.5M; participation from Khosla Ventures and SOSV/IndieBio
Series C activity recorded with announced date Mar 10, 2025
“Backed by institutional VCs including Celesta Capital, Khosla Ventures, SOSV/IndieBio, Avidity Partners, True Ventures, Black Diamond Ventures and others”
| Company |
|---|
Prellis Biologics uses proprietary technology to 3D print lymph node organoids, which we are using to generate invitrohumanlymphnodecoculturesfor generating antigen-specific B-cells.We are seeking a Research Associate – Senior Research Associate, Antibody Discovery to join our Antibody Discovery team.In this role you will be supporting high-throughput antibody discovery efforts, particularly using single B-cell approaches.The ideal candidate will have a strong background in molecular biology, with significant experience in supporting end-to-end antibody discovery campaigns.
Key Responsibilities
Qualifications
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week